1-5 of 5
Andrew Lewandowski
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase 1 Study of PIT565, a First-in-Class, Anti-CD3, Anti-CD19, Anti-CD2 Trispecific Antibody in Patients with Relapsed and/or Refractory B-Cell Malignancies

Irit Avivi Mazza, Pere Barba, Junichiro Yuda, Maria Lia Palomba, Juan Pablo Alderuccio, Ciel De Vriendt, Paolo Corradini, Francesca Lorraine Wei Inng Lim, Pier Luigi Zinzani, Nitin Jain, Jessica T. Leonard, Michelle Coulson, Nadia Hassounah, Xiaoling Yang, Haihui Lu, Andrew Lewandowski, Joseph Ryan Polli, Matthieu Klopfenstein, Alessandro Pastore, Gabriel Brisou
Journal: Blood
Blood (2023) 142 (Supplement 1): 3099.
https://doi.org/10.1182/blood-2023-179061
Published: 2023
Journal Articles

Canakinumab Effects on Erythropoiesis, Cardiovascular Risk, and Clonal Hematopoiesis: Proteogenomic Analysis of the Cantos Randomized Clinical Trial

Janghee Woo, Darlene Lu, Andrew Lewandowski, Paul M. Ridker, Benjamin L. Ebert, David Steensma
Journal: Blood
Blood (2022) 140 (Supplement 1): 2236–2237.
https://doi.org/10.1182/blood-2022-167275
Published: 2022
Journal Articles

Treatment of Individuals with Severe Sickle Cell Disease with OTQ923, an Autologous, Ex Vivo , CRISPR/Cas9-Edited, CD34+ Hematopoietic Stem and Progenitor Cell Product, Leads to Durable Engraftment and Fetal Hemoglobin Induction

Akshay Sharma, Jaap Jan Boelens, Maria I. Cancio, Jane Hankins, Prafulla A Bhad, Andrew Lewandowski, Xiaojun Zhao, Shripad Chitnis, Radhika Peddinti, Yan Zheng, Neena Kapoor, Fabio Ciceri, Jianping Yuan, Vionnie W. Yu, Susan C. Stevenson, Serena De Vita, James LaBelle
Journal: Blood
Blood (2022) 140 (Supplement 1): 1906–1908.
https://doi.org/10.1182/blood-2022-166254
Published: 2022
Journal Articles

Efficacy and Safety of Sabatolimab (MBG453) in Combination with Hypomethylating Agents (HMAs) in Patients (Pts) with Very High/High-Risk Myelodysplastic Syndrome (vHR/HR-MDS) and Acute Myeloid Leukemia (AML): Final Analysis from a Phase Ib Study

Andrew M. Brunner, Jordi Esteve, Kimmo Porkka, Steve Knapper, Elie Traer, Sebastian Scholl, Guillermo Garcia-Manero, Norbert Vey, Martin Wermke, Jeroen Janssen, Rupa Narayan, Sun Loo, Mika Kontro, Oliver Ottmann, Purushotham Naidu, Marc Pelletier, May Han, Andrew Lewandowski, Na Zhang, Anisa Mohammed, Mikael L. Rinne, Uma Borate, Andrew H. Wei, Natalia Tovar
Journal: Blood
Blood (2021) 138 (Supplement 1): 244.
https://doi.org/10.1182/blood-2021-146039
Published: 2021
Journal Articles

Ibrutinib before Apheresis May Improve Tisagenlecleucel Manufacturing in Relapsed/Refractory Adult Diffuse Large B-Cell Lymphoma: Initial Results from a Phase 1b Study

Julio C. Chavez, MD, Frederick L. Locke, MD, Ellen Napier, CRNP, Carl Simon, MS, Andrew Lewandowski, PhD, Rakesh Awasthi, PhD, Boris Engels, PhD, Petrina Georgala, PhD, Attilio Bondanza, MD, Stephen J. Schuster, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 3–4.
https://doi.org/10.1182/blood-2020-134270
Published: 2020